Pancreatic Cancer Research

ResearcherUniversity of Colorado AnschutzActive in the last 2 years

Kirk Charles Hansen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5054-838X; OpenAlex author ID A5076307322. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 8

  1. Pancreatic Cancer Progression Involves Increased Lysyl Oxidase-Mediated Collagen Cross-Links as Part of the Desmoplastic Reaction. Last author DOI 10.1021/acs.biochem.5c00125↗
  2. Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Co-author DOI 10.1038/s41591-023-02694-w↗
  3. A Multiomics Assessment of Preoperative Exercise in Pancreatic Cancer Survivors Receiving Neoadjuvant Therapy: A Case Series. Co-author DOI 10.3390/pathophysiology31010013↗
  4. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleoti… Co-author DOI 10.1007/s00262-020-02701-w↗
  5. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-3892↗
  6. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2019.08.015↗
  7. Compartment resolved proteomics reveals a dynamic matrisome in a biomechanically driven model of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.regen.2018.03.002↗
  8. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Co-author DOI 10.1038/nm.4082↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Valerie Marie Weaver · 4 shared papers, 2016–2025 · strength 0.55
  2. Alex Barrett · 3 shared papers, 2016–2025 · strength 0.45
  3. Wells A. Messersmith · 3 shared papers, 2021–2025 · strength 0.43
  4. Angelo D’Alessandro · 2 shared papers, 2019–2024 · strength 0.32
  5. Marco Del Chiaro · 3 shared papers, 2019–2021 · strength 0.28
  6. Richard David Schulick · 3 shared papers, 2019–2021 · strength 0.28
  7. Todd M. Pitts · 1 shared paper, 2025 · strength 0.25
  8. Travis G. Nemkov · 1 shared paper, 2024 · strength 0.23
  9. Ryan J. Marker · 1 shared paper, 2024 · strength 0.23
  10. Grace Kim · 2 shared papers, 2016–2024 · strength 0.20
  11. Hanane Laklai · 2 shared papers, 2016–2024 · strength 0.20
  12. Nilotpal Roy · 2 shared papers, 2016–2024 · strength 0.20
  13. Matthias Hebrok · 2 shared papers, 2016–2024 · strength 0.20
  14. Laura DeLong Wood · 2 shared papers, 2016–2024 · strength 0.20
  15. Eric Andrew Collisson · 2 shared papers, 2016–2024 · strength 0.20
  16. Raghu Kalluri · 2 shared papers, 2016–2024 · strength 0.20
  17. Harold L. Moses · 2 shared papers, 2016–2024 · strength 0.20
  18. Julia Sidenius Johansen · 2 shared papers, 2016–2024 · strength 0.20
  19. Christine A. Iacobuzio–Donahue · 2 shared papers, 2016–2024 · strength 0.20
  20. Michael James Gough · 2 shared papers, 2021 · strength 0.19
  21. Karyn A. Goodman · 2 shared papers, 2021 · strength 0.19
  22. Miles Piper · 2 shared papers, 2021 · strength 0.19
  23. Ayman J. Oweida · 2 shared papers, 2021 · strength 0.19
  24. Sana D. Karam · 2 shared papers, 2021 · strength 0.19
  25. Adam Christopher Mueller · 2 shared papers, 2021 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.